Related Experiment Video
Updated: Oct 27, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer
Danial Mehranfard1, Gabriela Perez2, Andres Rodriguez3
1College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
Materials And Methods:
Quantitative expression of the RNA of these 17 genes in normal and cancerous tissues obtained using chip arrays from the public functional genomics data repository, Gene Expression Omnibus (GEO) application, was compared statistically.
Results:
Expression of four genes, AGT (angiotensinogen), ENPEP (aminopeptidase A) MME (neprilysin), and PREP (prolyl endopeptidase), was significantly upregulated in CRC specimens. Expression of REN (renin), THOP (thimet oligopeptidase), NLN (neurolysin), PRCP (prolyl carboxypeptidase), ANPEP (aminopeptidase N), and MAS1 (Mas receptor) was downregulated in CRC specimens.
Conclusions:
Presuming gene expression parallel protein expression, these results suggest that increased production of the angiotensinogen precursor of angiotensin (ANG) peptides, with the reduction of the enzymes that metabolize it to ANG II, can lead to accumulation of angiotensinogen in CRC tissues. Downregulation of THOP, NLN, PRCP, and MAS1 gene expression, whose proteins contribute to the ACE2/ANG 1-7/Mas axis, suggests that reduced activity of this RAS branch could be permissive for oncogenicity. Components of the RAS may be potential therapeutic targets for treatment of CRC.
Insights
This study reveals altered gene expression in colorectal cancer (CRC). Key genes in the renin-angiotensin system (RAS) are dysregulated, suggesting potential therapeutic targets for CRC treatment.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- The renin-angiotensin system (RAS) plays a role in various physiological processes.
- Dysregulation of the RAS has been implicated in cancer development and progression.
Purpose of the Study:
- To investigate the expression patterns of specific RAS-related genes in colorectal cancer (CRC).
- To identify potential molecular mechanisms linking RAS to CRC oncogenicity.
Main Methods:
- Quantitative gene expression analysis using chip arrays.
- Statistical comparison of gene expression in normal versus cancerous tissues from the Gene Expression Omnibus (GEO) database.
Main Results:
- Upregulation of angiotensinogen (AGT), aminopeptidase A (ENPEP), neprilysin (MME), and prolyl endopeptidase (PREP) in CRC specimens.
- Downregulation of renin (REN), thimet oligopeptidase (THOP), neurolysin (NLN), prolyl carboxypeptidase (PRCP), aminopeptidase N (ANPEP), and Mas receptor (MAS1) in CRC specimens.
Conclusions:
- Altered expression of RAS components suggests a potential role in CRC development.
- Increased angiotensinogen and reduced metabolism may lead to angiotensinogen accumulation in CRC.
- Downregulation of the ACE2/ANG 1-7/Mas axis may promote oncogenicity.
- RAS components represent potential therapeutic targets for CRC treatment.
Related Concept Videos
Hormonal Regulation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin II Receptor Blockers

